These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 18582189)

  • 1. Relapse of tic symptoms in a patient diagnosed with obsessive-compulsive disorder and treated with high-dose paroxetine.
    Lee MS; Lee HY; Kim SH
    J Child Adolesc Psychopharmacol; 2008 Jun; 18(3):305-6. PubMed ID: 18582189
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methylphenidate, tics and compulsions].
    Guegant G; Crochette A
    Encephale; 2000; 26(2):45-7. PubMed ID: 10858915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
    Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
    [No Abstract]   [Full Text] [Related]  

  • 6. Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine.
    Keuthen NJ; Cyr P; Ricciardi JA; Minichiello WE; Buttolph ML; Jenike MA
    J Clin Psychopharmacol; 1994 Jun; 14(3):206-7. PubMed ID: 8027419
    [No Abstract]   [Full Text] [Related]  

  • 7. Paroxetine-induced enuresis.
    Toros F; Erdoğan K
    Eur Psychiatry; 2003 Feb; 18(1):43-4. PubMed ID: 12648899
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed-onset obsessive-compulsive symptoms after brain infarctions treated with paroxetine.
    Muneoka K; Shirayama Y; Kon K; Kawabe M; Kimura S
    Clin Neuropharmacol; 2011; 34(6):260-1. PubMed ID: 22104637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous vasculitis induced by paroxetine.
    Margolese HC; Chouinard G; Beauclair L; Rubino M
    Am J Psychiatry; 2001 Mar; 158(3):497. PubMed ID: 11230000
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of paroxetine-induced akathisia.
    Olivera AA
    Biol Psychiatry; 1996 May; 39(10):910. PubMed ID: 8860197
    [No Abstract]   [Full Text] [Related]  

  • 11. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
    Heiden A; de Zwaan M; Frey R; Presslich O; Kasper S
    J Psychiatry Neurosci; 1998 May; 23(3):179-80. PubMed ID: 9595892
    [No Abstract]   [Full Text] [Related]  

  • 12. Obsessive-compulsive disorder with and without tics in a clinical sample of children and adolescents.
    Hanna GL; Piacentini J; Cantwell DP; Fischer DJ; Himle JA; Van Etten M
    Depress Anxiety; 2002; 16(2):59-63. PubMed ID: 12219336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.
    Findling RL; Nucci G; Piergies AA; Gomeni R; Bartolic EI; Fong R; Carpenter DJ; Leeder JS; Gaedigk A; Danoff TM
    Neuropsychopharmacology; 2006 Jun; 31(6):1274-85. PubMed ID: 16319918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine and obsessive-compulsive disorder.
    Kaye NS; Dancu C
    Am J Psychiatry; 1994 Oct; 151(10):1523. PubMed ID: 8092350
    [No Abstract]   [Full Text] [Related]  

  • 15. Group behavioral therapy for adolescents with tic-related and non-tic-related obsessive-compulsive disorder.
    Himle JA; Fischer DJ; Van Etten ML; Janeck AS; Hanna GL
    Depress Anxiety; 2003; 17(2):73-7. PubMed ID: 12621595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
    Poyurovsky M; Faragian S; Shabeta A; Kosov A
    Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine-induced psychotic mania.
    Christensen RC
    Am J Psychiatry; 1995 Sep; 152(9):1399-400. PubMed ID: 7653703
    [No Abstract]   [Full Text] [Related]  

  • 18. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children.
    Leonard HL; Lenane MC; Swedo SE; Rettew DC; Gershon ES; Rapoport JL
    Am J Psychiatry; 1992 Sep; 149(9):1244-51. PubMed ID: 1503140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine for the treatment of onychotillomania associated with obsessive-compulsive disorder: a case report.
    Aljhani S
    J Med Case Rep; 2022 Nov; 16(1):431. PubMed ID: 36403006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical symptoms associated with paroxetine discontinuation.
    Barr LC; Goodman WK; Price LH
    Am J Psychiatry; 1994 Feb; 151(2):289. PubMed ID: 8296907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.